SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial
Raquibul Hannan, Samer Salamekh, Neil Desai, Aurélie Garant, Michael R. Folkert, Daniel N. Costa, Samantha Mannala, Chul Ahn, Osama Mohamad, Aaron Laine, Dong W. Nathan Kim, T. Dickinson, Ganesh V. Raj, Rajal B. Shah, Jing Wang, Xun Jia, Hak Choy, Claus G. Roehrborn, Yair Lotan, Robert Timmerman
Topics & Concepts
SABR volatility modelProstate cancerMedicineDe-escalationOncologyProspective cohort studyCancerInternal medicineBusinessStochastic volatilityVolatility (finance)FinanceProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchMRI in cancer diagnosis